nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—schizophrenia—Dimenhydrinate—atopic dermatitis	0.27	0.569	CpDpCtD
Risperidone—schizophrenia—Diphenhydramine—atopic dermatitis	0.204	0.431	CpDpCtD
Risperidone—HRH1—Dimenhydrinate—atopic dermatitis	0.0412	0.121	CbGbCtD
Risperidone—KCNH2—Loratadine—atopic dermatitis	0.0342	0.101	CbGbCtD
Risperidone—CYP3A7—Tacrolimus—atopic dermatitis	0.0239	0.0703	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0239	0.0703	CbGbCtD
Risperidone—HRH1—Diphenhydramine—atopic dermatitis	0.0201	0.0593	CbGbCtD
Risperidone—HRH1—Loratadine—atopic dermatitis	0.0201	0.0593	CbGbCtD
Risperidone—CYP3A5—Tacrolimus—atopic dermatitis	0.0179	0.0528	CbGbCtD
Risperidone—CYP3A4—Pimecrolimus—atopic dermatitis	0.0117	0.0346	CbGbCtD
Risperidone—ABCB1—Tacrolimus—atopic dermatitis	0.0117	0.0343	CbGbCtD
Risperidone—CYP3A7—Hydrocortisone—atopic dermatitis	0.00972	0.0286	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.00972	0.0286	CbGbCtD
Risperidone—ABCB1—Loratadine—atopic dermatitis	0.00853	0.0251	CbGbCtD
Risperidone—CYP2D6—Diphenhydramine—atopic dermatitis	0.00804	0.0237	CbGbCtD
Risperidone—CYP2D6—Loratadine—atopic dermatitis	0.00804	0.0237	CbGbCtD
Risperidone—ABCB1—Methylprednisolone—atopic dermatitis	0.0078	0.023	CbGbCtD
Risperidone—CYP3A5—Hydrocortisone—atopic dermatitis	0.00729	0.0215	CbGbCtD
Risperidone—CYP3A4—Tacrolimus—atopic dermatitis	0.00698	0.0206	CbGbCtD
Risperidone—CYP3A7—Dexamethasone—atopic dermatitis	0.00604	0.0178	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00604	0.0178	CbGbCtD
Risperidone—CYP3A4—Loratadine—atopic dermatitis	0.00511	0.0151	CbGbCtD
Risperidone—ABCB1—Betamethasone—atopic dermatitis	0.00507	0.0149	CbGbCtD
Risperidone—ABCB1—Prednisolone—atopic dermatitis	0.005	0.0147	CbGbCtD
Risperidone—ABCB1—Hydrocortisone—atopic dermatitis	0.00474	0.014	CbGbCtD
Risperidone—ABCB1—Prednisone—atopic dermatitis	0.00473	0.0139	CbGbCtD
Risperidone—CYP3A4—Methylprednisolone—atopic dermatitis	0.00467	0.0138	CbGbCtD
Risperidone—CYP3A5—Dexamethasone—atopic dermatitis	0.00453	0.0134	CbGbCtD
Risperidone—CYP3A4—Triamcinolone—atopic dermatitis	0.00354	0.0104	CbGbCtD
Risperidone—CYP3A4—Betamethasone—atopic dermatitis	0.00304	0.00896	CbGbCtD
Risperidone—CYP3A4—Prednisolone—atopic dermatitis	0.003	0.00884	CbGbCtD
Risperidone—ABCB1—Dexamethasone—atopic dermatitis	0.00295	0.00869	CbGbCtD
Risperidone—CYP3A4—Hydrocortisone—atopic dermatitis	0.00284	0.00838	CbGbCtD
Risperidone—CYP3A4—Prednisone—atopic dermatitis	0.00283	0.00834	CbGbCtD
Risperidone—CYP2D6—Dexamethasone—atopic dermatitis	0.00278	0.00819	CbGbCtD
Risperidone—CYP3A4—Dexamethasone—atopic dermatitis	0.00177	0.00521	CbGbCtD
Risperidone—Convulsion—Methylprednisolone—atopic dermatitis	3.1e-05	0.000217	CcSEcCtD
Risperidone—Hypertension—Triamcinolone—atopic dermatitis	3.09e-05	0.000217	CcSEcCtD
Risperidone—Hypertension—Methylprednisolone—atopic dermatitis	3.09e-05	0.000216	CcSEcCtD
Risperidone—Infection—Hydrocortisone—atopic dermatitis	3.09e-05	0.000216	CcSEcCtD
Risperidone—Hyperhidrosis—Prednisolone—atopic dermatitis	3.07e-05	0.000215	CcSEcCtD
Risperidone—Shock—Hydrocortisone—atopic dermatitis	3.06e-05	0.000214	CcSEcCtD
Risperidone—Myalgia—Triamcinolone—atopic dermatitis	3.05e-05	0.000214	CcSEcCtD
Risperidone—Nervous system disorder—Hydrocortisone—atopic dermatitis	3.05e-05	0.000213	CcSEcCtD
Risperidone—Myalgia—Methylprednisolone—atopic dermatitis	3.04e-05	0.000213	CcSEcCtD
Risperidone—Arthralgia—Methylprednisolone—atopic dermatitis	3.04e-05	0.000213	CcSEcCtD
Risperidone—Eye disorder—Prednisone—atopic dermatitis	3.04e-05	0.000213	CcSEcCtD
Risperidone—Anxiety—Methylprednisolone—atopic dermatitis	3.03e-05	0.000213	CcSEcCtD
Risperidone—Tachycardia—Hydrocortisone—atopic dermatitis	3.03e-05	0.000212	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	3.02e-05	0.000212	CcSEcCtD
Risperidone—Flushing—Prednisone—atopic dermatitis	3.02e-05	0.000212	CcSEcCtD
Risperidone—Skin disorder—Hydrocortisone—atopic dermatitis	3.02e-05	0.000211	CcSEcCtD
Risperidone—Ill-defined disorder—Betamethasone—atopic dermatitis	3.02e-05	0.000211	CcSEcCtD
Risperidone—Ill-defined disorder—Dexamethasone—atopic dermatitis	3.02e-05	0.000211	CcSEcCtD
Risperidone—Discomfort—Triamcinolone—atopic dermatitis	3.01e-05	0.000211	CcSEcCtD
Risperidone—Discomfort—Methylprednisolone—atopic dermatitis	3.01e-05	0.000211	CcSEcCtD
Risperidone—Hyperhidrosis—Hydrocortisone—atopic dermatitis	3e-05	0.00021	CcSEcCtD
Risperidone—Dry mouth—Triamcinolone—atopic dermatitis	2.98e-05	0.000209	CcSEcCtD
Risperidone—Angioedema—Dexamethasone—atopic dermatitis	2.97e-05	0.000208	CcSEcCtD
Risperidone—Angioedema—Betamethasone—atopic dermatitis	2.97e-05	0.000208	CcSEcCtD
Risperidone—Anorexia—Hydrocortisone—atopic dermatitis	2.96e-05	0.000207	CcSEcCtD
Risperidone—Nausea—Tacrolimus—atopic dermatitis	2.96e-05	0.000207	CcSEcCtD
Risperidone—Angiopathy—Prednisone—atopic dermatitis	2.95e-05	0.000207	CcSEcCtD
Risperidone—Confusional state—Methylprednisolone—atopic dermatitis	2.94e-05	0.000206	CcSEcCtD
Risperidone—Immune system disorder—Prednisone—atopic dermatitis	2.94e-05	0.000206	CcSEcCtD
Risperidone—Malaise—Betamethasone—atopic dermatitis	2.93e-05	0.000205	CcSEcCtD
Risperidone—Malaise—Dexamethasone—atopic dermatitis	2.93e-05	0.000205	CcSEcCtD
Risperidone—Oedema—Triamcinolone—atopic dermatitis	2.92e-05	0.000205	CcSEcCtD
Risperidone—Anaphylactic shock—Triamcinolone—atopic dermatitis	2.92e-05	0.000205	CcSEcCtD
Risperidone—Vertigo—Dexamethasone—atopic dermatitis	2.92e-05	0.000205	CcSEcCtD
Risperidone—Vertigo—Betamethasone—atopic dermatitis	2.92e-05	0.000205	CcSEcCtD
Risperidone—Anaphylactic shock—Methylprednisolone—atopic dermatitis	2.92e-05	0.000205	CcSEcCtD
Risperidone—Syncope—Betamethasone—atopic dermatitis	2.92e-05	0.000204	CcSEcCtD
Risperidone—Syncope—Dexamethasone—atopic dermatitis	2.92e-05	0.000204	CcSEcCtD
Risperidone—Arrhythmia—Prednisone—atopic dermatitis	2.91e-05	0.000204	CcSEcCtD
Risperidone—Infection—Triamcinolone—atopic dermatitis	2.91e-05	0.000204	CcSEcCtD
Risperidone—Hypotension—Hydrocortisone—atopic dermatitis	2.9e-05	0.000203	CcSEcCtD
Risperidone—Infection—Methylprednisolone—atopic dermatitis	2.9e-05	0.000203	CcSEcCtD
Risperidone—Shock—Triamcinolone—atopic dermatitis	2.88e-05	0.000202	CcSEcCtD
Risperidone—Insomnia—Prednisolone—atopic dermatitis	2.88e-05	0.000202	CcSEcCtD
Risperidone—Alopecia—Prednisone—atopic dermatitis	2.87e-05	0.000201	CcSEcCtD
Risperidone—Shock—Methylprednisolone—atopic dermatitis	2.87e-05	0.000201	CcSEcCtD
Risperidone—Nervous system disorder—Methylprednisolone—atopic dermatitis	2.86e-05	0.000201	CcSEcCtD
Risperidone—Loss of consciousness—Dexamethasone—atopic dermatitis	2.86e-05	0.0002	CcSEcCtD
Risperidone—Loss of consciousness—Betamethasone—atopic dermatitis	2.86e-05	0.0002	CcSEcCtD
Risperidone—Paraesthesia—Prednisolone—atopic dermatitis	2.86e-05	0.0002	CcSEcCtD
Risperidone—Tachycardia—Triamcinolone—atopic dermatitis	2.85e-05	0.0002	CcSEcCtD
Risperidone—Mental disorder—Prednisone—atopic dermatitis	2.85e-05	0.0002	CcSEcCtD
Risperidone—Tachycardia—Methylprednisolone—atopic dermatitis	2.85e-05	0.0002	CcSEcCtD
Risperidone—Skin disorder—Methylprednisolone—atopic dermatitis	2.83e-05	0.000199	CcSEcCtD
Risperidone—Erythema—Prednisone—atopic dermatitis	2.83e-05	0.000198	CcSEcCtD
Risperidone—Malnutrition—Prednisone—atopic dermatitis	2.83e-05	0.000198	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	2.83e-05	0.000198	CcSEcCtD
Risperidone—Hyperhidrosis—Triamcinolone—atopic dermatitis	2.83e-05	0.000198	CcSEcCtD
Risperidone—Hyperhidrosis—Methylprednisolone—atopic dermatitis	2.82e-05	0.000198	CcSEcCtD
Risperidone—Convulsion—Dexamethasone—atopic dermatitis	2.82e-05	0.000197	CcSEcCtD
Risperidone—Convulsion—Betamethasone—atopic dermatitis	2.82e-05	0.000197	CcSEcCtD
Risperidone—Insomnia—Hydrocortisone—atopic dermatitis	2.81e-05	0.000197	CcSEcCtD
Risperidone—Hypertension—Dexamethasone—atopic dermatitis	2.81e-05	0.000197	CcSEcCtD
Risperidone—Hypertension—Betamethasone—atopic dermatitis	2.81e-05	0.000197	CcSEcCtD
Risperidone—Paraesthesia—Hydrocortisone—atopic dermatitis	2.79e-05	0.000195	CcSEcCtD
Risperidone—Myalgia—Betamethasone—atopic dermatitis	2.77e-05	0.000194	CcSEcCtD
Risperidone—Myalgia—Dexamethasone—atopic dermatitis	2.77e-05	0.000194	CcSEcCtD
Risperidone—Anxiety—Betamethasone—atopic dermatitis	2.76e-05	0.000193	CcSEcCtD
Risperidone—Anxiety—Dexamethasone—atopic dermatitis	2.76e-05	0.000193	CcSEcCtD
Risperidone—Discomfort—Betamethasone—atopic dermatitis	2.74e-05	0.000192	CcSEcCtD
Risperidone—Discomfort—Dexamethasone—atopic dermatitis	2.74e-05	0.000192	CcSEcCtD
Risperidone—Dyspepsia—Hydrocortisone—atopic dermatitis	2.73e-05	0.000192	CcSEcCtD
Risperidone—Hypotension—Methylprednisolone—atopic dermatitis	2.73e-05	0.000191	CcSEcCtD
Risperidone—Pain—Prednisolone—atopic dermatitis	2.72e-05	0.000191	CcSEcCtD
Risperidone—Decreased appetite—Hydrocortisone—atopic dermatitis	2.7e-05	0.000189	CcSEcCtD
Risperidone—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	2.68e-05	0.000188	CcSEcCtD
Risperidone—Fatigue—Hydrocortisone—atopic dermatitis	2.68e-05	0.000188	CcSEcCtD
Risperidone—Vision blurred—Prednisone—atopic dermatitis	2.67e-05	0.000187	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	2.66e-05	0.000187	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	2.66e-05	0.000186	CcSEcCtD
Risperidone—Pain—Hydrocortisone—atopic dermatitis	2.66e-05	0.000186	CcSEcCtD
Risperidone—Oedema—Dexamethasone—atopic dermatitis	2.65e-05	0.000186	CcSEcCtD
Risperidone—Oedema—Betamethasone—atopic dermatitis	2.65e-05	0.000186	CcSEcCtD
Risperidone—Anaphylactic shock—Betamethasone—atopic dermatitis	2.65e-05	0.000186	CcSEcCtD
Risperidone—Anaphylactic shock—Dexamethasone—atopic dermatitis	2.65e-05	0.000186	CcSEcCtD
Risperidone—Insomnia—Triamcinolone—atopic dermatitis	2.65e-05	0.000185	CcSEcCtD
Risperidone—Insomnia—Methylprednisolone—atopic dermatitis	2.64e-05	0.000185	CcSEcCtD
Risperidone—Infection—Betamethasone—atopic dermatitis	2.64e-05	0.000185	CcSEcCtD
Risperidone—Infection—Dexamethasone—atopic dermatitis	2.64e-05	0.000185	CcSEcCtD
Risperidone—Ill-defined disorder—Prednisone—atopic dermatitis	2.63e-05	0.000184	CcSEcCtD
Risperidone—Paraesthesia—Triamcinolone—atopic dermatitis	2.63e-05	0.000184	CcSEcCtD
Risperidone—Feeling abnormal—Prednisolone—atopic dermatitis	2.62e-05	0.000184	CcSEcCtD
Risperidone—Paraesthesia—Methylprednisolone—atopic dermatitis	2.62e-05	0.000184	CcSEcCtD
Risperidone—Anaemia—Prednisone—atopic dermatitis	2.62e-05	0.000183	CcSEcCtD
Risperidone—Shock—Dexamethasone—atopic dermatitis	2.61e-05	0.000183	CcSEcCtD
Risperidone—Shock—Betamethasone—atopic dermatitis	2.61e-05	0.000183	CcSEcCtD
Risperidone—Dyspnoea—Triamcinolone—atopic dermatitis	2.61e-05	0.000183	CcSEcCtD
Risperidone—Nervous system disorder—Betamethasone—atopic dermatitis	2.6e-05	0.000182	CcSEcCtD
Risperidone—Nervous system disorder—Dexamethasone—atopic dermatitis	2.6e-05	0.000182	CcSEcCtD
Risperidone—Agitation—Prednisone—atopic dermatitis	2.6e-05	0.000182	CcSEcCtD
Risperidone—Thrombocytopenia—Betamethasone—atopic dermatitis	2.6e-05	0.000182	CcSEcCtD
Risperidone—Thrombocytopenia—Dexamethasone—atopic dermatitis	2.6e-05	0.000182	CcSEcCtD
Risperidone—Tachycardia—Betamethasone—atopic dermatitis	2.59e-05	0.000182	CcSEcCtD
Risperidone—Tachycardia—Dexamethasone—atopic dermatitis	2.59e-05	0.000182	CcSEcCtD
Risperidone—Angioedema—Prednisone—atopic dermatitis	2.59e-05	0.000181	CcSEcCtD
Risperidone—Dyspepsia—Triamcinolone—atopic dermatitis	2.57e-05	0.00018	CcSEcCtD
Risperidone—Dyspepsia—Methylprednisolone—atopic dermatitis	2.57e-05	0.00018	CcSEcCtD
Risperidone—Hyperhidrosis—Betamethasone—atopic dermatitis	2.57e-05	0.00018	CcSEcCtD
Risperidone—Hyperhidrosis—Dexamethasone—atopic dermatitis	2.57e-05	0.00018	CcSEcCtD
Risperidone—Feeling abnormal—Hydrocortisone—atopic dermatitis	2.56e-05	0.000179	CcSEcCtD
Risperidone—Malaise—Prednisone—atopic dermatitis	2.55e-05	0.000179	CcSEcCtD
Risperidone—Vertigo—Prednisone—atopic dermatitis	2.54e-05	0.000178	CcSEcCtD
Risperidone—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	2.54e-05	0.000178	CcSEcCtD
Risperidone—Syncope—Prednisone—atopic dermatitis	2.54e-05	0.000178	CcSEcCtD
Risperidone—Anorexia—Betamethasone—atopic dermatitis	2.53e-05	0.000177	CcSEcCtD
Risperidone—Anorexia—Dexamethasone—atopic dermatitis	2.53e-05	0.000177	CcSEcCtD
Risperidone—Urticaria—Prednisolone—atopic dermatitis	2.53e-05	0.000177	CcSEcCtD
Risperidone—Fatigue—Triamcinolone—atopic dermatitis	2.52e-05	0.000177	CcSEcCtD
Risperidone—Fatigue—Methylprednisolone—atopic dermatitis	2.52e-05	0.000176	CcSEcCtD
Risperidone—Pain—Triamcinolone—atopic dermatitis	2.5e-05	0.000175	CcSEcCtD
Risperidone—Loss of consciousness—Prednisone—atopic dermatitis	2.49e-05	0.000174	CcSEcCtD
Risperidone—Hypotension—Betamethasone—atopic dermatitis	2.48e-05	0.000174	CcSEcCtD
Risperidone—Hypotension—Dexamethasone—atopic dermatitis	2.48e-05	0.000174	CcSEcCtD
Risperidone—Urticaria—Hydrocortisone—atopic dermatitis	2.47e-05	0.000173	CcSEcCtD
Risperidone—Body temperature increased—Hydrocortisone—atopic dermatitis	2.46e-05	0.000172	CcSEcCtD
Risperidone—Abdominal pain—Hydrocortisone—atopic dermatitis	2.46e-05	0.000172	CcSEcCtD
Risperidone—Convulsion—Prednisone—atopic dermatitis	2.45e-05	0.000172	CcSEcCtD
Risperidone—Hypertension—Prednisone—atopic dermatitis	2.44e-05	0.000171	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	2.42e-05	0.000169	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	2.42e-05	0.000169	CcSEcCtD
Risperidone—Arthralgia—Prednisone—atopic dermatitis	2.41e-05	0.000169	CcSEcCtD
Risperidone—Myalgia—Prednisone—atopic dermatitis	2.41e-05	0.000169	CcSEcCtD
Risperidone—Feeling abnormal—Triamcinolone—atopic dermatitis	2.41e-05	0.000169	CcSEcCtD
Risperidone—Feeling abnormal—Methylprednisolone—atopic dermatitis	2.4e-05	0.000169	CcSEcCtD
Risperidone—Anxiety—Prednisone—atopic dermatitis	2.4e-05	0.000168	CcSEcCtD
Risperidone—Insomnia—Dexamethasone—atopic dermatitis	2.4e-05	0.000168	CcSEcCtD
Risperidone—Insomnia—Betamethasone—atopic dermatitis	2.4e-05	0.000168	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	2.39e-05	0.000168	CcSEcCtD
Risperidone—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	2.39e-05	0.000167	CcSEcCtD
Risperidone—Paraesthesia—Betamethasone—atopic dermatitis	2.38e-05	0.000167	CcSEcCtD
Risperidone—Paraesthesia—Dexamethasone—atopic dermatitis	2.38e-05	0.000167	CcSEcCtD
Risperidone—Discomfort—Prednisone—atopic dermatitis	2.38e-05	0.000167	CcSEcCtD
Risperidone—Hypersensitivity—Prednisolone—atopic dermatitis	2.34e-05	0.000164	CcSEcCtD
Risperidone—Dyspepsia—Betamethasone—atopic dermatitis	2.34e-05	0.000164	CcSEcCtD
Risperidone—Dyspepsia—Dexamethasone—atopic dermatitis	2.34e-05	0.000164	CcSEcCtD
Risperidone—Urticaria—Triamcinolone—atopic dermatitis	2.32e-05	0.000163	CcSEcCtD
Risperidone—Urticaria—Methylprednisolone—atopic dermatitis	2.32e-05	0.000162	CcSEcCtD
Risperidone—Body temperature increased—Triamcinolone—atopic dermatitis	2.31e-05	0.000162	CcSEcCtD
Risperidone—Oedema—Prednisone—atopic dermatitis	2.31e-05	0.000162	CcSEcCtD
Risperidone—Anaphylactic shock—Prednisone—atopic dermatitis	2.31e-05	0.000162	CcSEcCtD
Risperidone—Abdominal pain—Methylprednisolone—atopic dermatitis	2.31e-05	0.000162	CcSEcCtD
Risperidone—Decreased appetite—Dexamethasone—atopic dermatitis	2.31e-05	0.000162	CcSEcCtD
Risperidone—Decreased appetite—Betamethasone—atopic dermatitis	2.31e-05	0.000162	CcSEcCtD
Risperidone—Infection—Prednisone—atopic dermatitis	2.3e-05	0.000161	CcSEcCtD
Risperidone—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	2.29e-05	0.000161	CcSEcCtD
Risperidone—Gastrointestinal disorder—Betamethasone—atopic dermatitis	2.29e-05	0.000161	CcSEcCtD
Risperidone—Hypersensitivity—Hydrocortisone—atopic dermatitis	2.29e-05	0.00016	CcSEcCtD
Risperidone—Fatigue—Dexamethasone—atopic dermatitis	2.29e-05	0.00016	CcSEcCtD
Risperidone—Fatigue—Betamethasone—atopic dermatitis	2.29e-05	0.00016	CcSEcCtD
Risperidone—Shock—Prednisone—atopic dermatitis	2.27e-05	0.000159	CcSEcCtD
Risperidone—Pain—Betamethasone—atopic dermatitis	2.27e-05	0.000159	CcSEcCtD
Risperidone—Pain—Dexamethasone—atopic dermatitis	2.27e-05	0.000159	CcSEcCtD
Risperidone—Nervous system disorder—Prednisone—atopic dermatitis	2.27e-05	0.000159	CcSEcCtD
Risperidone—Tachycardia—Prednisone—atopic dermatitis	2.26e-05	0.000158	CcSEcCtD
Risperidone—Skin disorder—Prednisone—atopic dermatitis	2.24e-05	0.000157	CcSEcCtD
Risperidone—Hyperhidrosis—Prednisone—atopic dermatitis	2.23e-05	0.000157	CcSEcCtD
Risperidone—Asthenia—Hydrocortisone—atopic dermatitis	2.23e-05	0.000156	CcSEcCtD
Risperidone—Anorexia—Prednisone—atopic dermatitis	2.2e-05	0.000154	CcSEcCtD
Risperidone—Pruritus—Hydrocortisone—atopic dermatitis	2.2e-05	0.000154	CcSEcCtD
Risperidone—Feeling abnormal—Betamethasone—atopic dermatitis	2.19e-05	0.000153	CcSEcCtD
Risperidone—Feeling abnormal—Dexamethasone—atopic dermatitis	2.19e-05	0.000153	CcSEcCtD
Risperidone—Gastrointestinal pain—Betamethasone—atopic dermatitis	2.17e-05	0.000152	CcSEcCtD
Risperidone—Gastrointestinal pain—Dexamethasone—atopic dermatitis	2.17e-05	0.000152	CcSEcCtD
Risperidone—Hypersensitivity—Triamcinolone—atopic dermatitis	2.15e-05	0.000151	CcSEcCtD
Risperidone—Hypersensitivity—Methylprednisolone—atopic dermatitis	2.15e-05	0.000151	CcSEcCtD
Risperidone—Diarrhoea—Hydrocortisone—atopic dermatitis	2.13e-05	0.000149	CcSEcCtD
Risperidone—Urticaria—Betamethasone—atopic dermatitis	2.11e-05	0.000148	CcSEcCtD
Risperidone—Urticaria—Dexamethasone—atopic dermatitis	2.11e-05	0.000148	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Prednisone—atopic dermatitis	2.11e-05	0.000148	CcSEcCtD
Risperidone—Dizziness—Prednisolone—atopic dermatitis	2.1e-05	0.000147	CcSEcCtD
Risperidone—Asthenia—Triamcinolone—atopic dermatitis	2.1e-05	0.000147	CcSEcCtD
Risperidone—Abdominal pain—Betamethasone—atopic dermatitis	2.1e-05	0.000147	CcSEcCtD
Risperidone—Abdominal pain—Dexamethasone—atopic dermatitis	2.1e-05	0.000147	CcSEcCtD
Risperidone—Body temperature increased—Dexamethasone—atopic dermatitis	2.1e-05	0.000147	CcSEcCtD
Risperidone—Body temperature increased—Betamethasone—atopic dermatitis	2.1e-05	0.000147	CcSEcCtD
Risperidone—Asthenia—Methylprednisolone—atopic dermatitis	2.09e-05	0.000147	CcSEcCtD
Risperidone—Insomnia—Prednisone—atopic dermatitis	2.09e-05	0.000146	CcSEcCtD
Risperidone—Paraesthesia—Prednisone—atopic dermatitis	2.08e-05	0.000145	CcSEcCtD
Risperidone—Pruritus—Triamcinolone—atopic dermatitis	2.07e-05	0.000145	CcSEcCtD
Risperidone—Pruritus—Methylprednisolone—atopic dermatitis	2.06e-05	0.000145	CcSEcCtD
Risperidone—Dizziness—Hydrocortisone—atopic dermatitis	2.05e-05	0.000144	CcSEcCtD
Risperidone—Dyspepsia—Prednisone—atopic dermatitis	2.03e-05	0.000143	CcSEcCtD
Risperidone—Decreased appetite—Prednisone—atopic dermatitis	2.01e-05	0.000141	CcSEcCtD
Risperidone—Rash—Prednisolone—atopic dermatitis	2.01e-05	0.000141	CcSEcCtD
Risperidone—Dermatitis—Prednisolone—atopic dermatitis	2e-05	0.00014	CcSEcCtD
Risperidone—Diarrhoea—Methylprednisolone—atopic dermatitis	2e-05	0.00014	CcSEcCtD
Risperidone—Fatigue—Prednisone—atopic dermatitis	1.99e-05	0.00014	CcSEcCtD
Risperidone—Headache—Prednisolone—atopic dermatitis	1.99e-05	0.00014	CcSEcCtD
Risperidone—Constipation—Prednisone—atopic dermatitis	1.98e-05	0.000138	CcSEcCtD
Risperidone—Vomiting—Hydrocortisone—atopic dermatitis	1.97e-05	0.000138	CcSEcCtD
Risperidone—Rash—Hydrocortisone—atopic dermatitis	1.96e-05	0.000137	CcSEcCtD
Risperidone—Dermatitis—Hydrocortisone—atopic dermatitis	1.96e-05	0.000137	CcSEcCtD
Risperidone—Headache—Hydrocortisone—atopic dermatitis	1.95e-05	0.000136	CcSEcCtD
Risperidone—Dizziness—Triamcinolone—atopic dermatitis	1.93e-05	0.000136	CcSEcCtD
Risperidone—Dizziness—Methylprednisolone—atopic dermatitis	1.93e-05	0.000135	CcSEcCtD
Risperidone—Feeling abnormal—Prednisone—atopic dermatitis	1.9e-05	0.000133	CcSEcCtD
Risperidone—Asthenia—Betamethasone—atopic dermatitis	1.9e-05	0.000133	CcSEcCtD
Risperidone—Asthenia—Dexamethasone—atopic dermatitis	1.9e-05	0.000133	CcSEcCtD
Risperidone—Gastrointestinal pain—Prednisone—atopic dermatitis	1.89e-05	0.000132	CcSEcCtD
Risperidone—Nausea—Prednisolone—atopic dermatitis	1.89e-05	0.000132	CcSEcCtD
Risperidone—Pruritus—Betamethasone—atopic dermatitis	1.88e-05	0.000132	CcSEcCtD
Risperidone—Pruritus—Dexamethasone—atopic dermatitis	1.88e-05	0.000132	CcSEcCtD
Risperidone—Vomiting—Triamcinolone—atopic dermatitis	1.86e-05	0.00013	CcSEcCtD
Risperidone—Vomiting—Methylprednisolone—atopic dermatitis	1.86e-05	0.00013	CcSEcCtD
Risperidone—Nausea—Hydrocortisone—atopic dermatitis	1.84e-05	0.000129	CcSEcCtD
Risperidone—Rash—Triamcinolone—atopic dermatitis	1.84e-05	0.000129	CcSEcCtD
Risperidone—Dermatitis—Triamcinolone—atopic dermatitis	1.84e-05	0.000129	CcSEcCtD
Risperidone—Rash—Methylprednisolone—atopic dermatitis	1.84e-05	0.000129	CcSEcCtD
Risperidone—Dermatitis—Methylprednisolone—atopic dermatitis	1.84e-05	0.000129	CcSEcCtD
Risperidone—Urticaria—Prednisone—atopic dermatitis	1.84e-05	0.000129	CcSEcCtD
Risperidone—Headache—Triamcinolone—atopic dermatitis	1.83e-05	0.000128	CcSEcCtD
Risperidone—Headache—Methylprednisolone—atopic dermatitis	1.83e-05	0.000128	CcSEcCtD
Risperidone—Abdominal pain—Prednisone—atopic dermatitis	1.83e-05	0.000128	CcSEcCtD
Risperidone—Body temperature increased—Prednisone—atopic dermatitis	1.83e-05	0.000128	CcSEcCtD
Risperidone—Diarrhoea—Dexamethasone—atopic dermatitis	1.82e-05	0.000127	CcSEcCtD
Risperidone—Diarrhoea—Betamethasone—atopic dermatitis	1.82e-05	0.000127	CcSEcCtD
Risperidone—Dizziness—Betamethasone—atopic dermatitis	1.75e-05	0.000123	CcSEcCtD
Risperidone—Dizziness—Dexamethasone—atopic dermatitis	1.75e-05	0.000123	CcSEcCtD
Risperidone—Nausea—Triamcinolone—atopic dermatitis	1.74e-05	0.000122	CcSEcCtD
Risperidone—Nausea—Methylprednisolone—atopic dermatitis	1.73e-05	0.000121	CcSEcCtD
Risperidone—Hypersensitivity—Prednisone—atopic dermatitis	1.7e-05	0.000119	CcSEcCtD
Risperidone—Vomiting—Betamethasone—atopic dermatitis	1.69e-05	0.000118	CcSEcCtD
Risperidone—Vomiting—Dexamethasone—atopic dermatitis	1.69e-05	0.000118	CcSEcCtD
Risperidone—Rash—Betamethasone—atopic dermatitis	1.67e-05	0.000117	CcSEcCtD
Risperidone—Rash—Dexamethasone—atopic dermatitis	1.67e-05	0.000117	CcSEcCtD
Risperidone—Dermatitis—Betamethasone—atopic dermatitis	1.67e-05	0.000117	CcSEcCtD
Risperidone—Dermatitis—Dexamethasone—atopic dermatitis	1.67e-05	0.000117	CcSEcCtD
Risperidone—Headache—Betamethasone—atopic dermatitis	1.66e-05	0.000117	CcSEcCtD
Risperidone—Headache—Dexamethasone—atopic dermatitis	1.66e-05	0.000117	CcSEcCtD
Risperidone—Asthenia—Prednisone—atopic dermatitis	1.66e-05	0.000116	CcSEcCtD
Risperidone—Pruritus—Prednisone—atopic dermatitis	1.64e-05	0.000115	CcSEcCtD
Risperidone—Diarrhoea—Prednisone—atopic dermatitis	1.58e-05	0.000111	CcSEcCtD
Risperidone—Nausea—Dexamethasone—atopic dermatitis	1.58e-05	0.00011	CcSEcCtD
Risperidone—Nausea—Betamethasone—atopic dermatitis	1.58e-05	0.00011	CcSEcCtD
Risperidone—Dizziness—Prednisone—atopic dermatitis	1.53e-05	0.000107	CcSEcCtD
Risperidone—Vomiting—Prednisone—atopic dermatitis	1.47e-05	0.000103	CcSEcCtD
Risperidone—Rash—Prednisone—atopic dermatitis	1.46e-05	0.000102	CcSEcCtD
Risperidone—Dermatitis—Prednisone—atopic dermatitis	1.46e-05	0.000102	CcSEcCtD
Risperidone—Headache—Prednisone—atopic dermatitis	1.45e-05	0.000101	CcSEcCtD
Risperidone—Nausea—Prednisone—atopic dermatitis	1.37e-05	9.62e-05	CcSEcCtD
Risperidone—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	7.6e-06	0.000173	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NPS—atopic dermatitis	7.6e-06	0.000173	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NPS—atopic dermatitis	7.58e-06	0.000173	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TAC1—atopic dermatitis	7.58e-06	0.000173	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	7.58e-06	0.000172	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—IL2—atopic dermatitis	7.53e-06	0.000171	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	7.52e-06	0.000171	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—NGF—atopic dermatitis	7.5e-06	0.000171	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—CXCL8—atopic dermatitis	7.47e-06	0.00017	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	7.45e-06	0.00017	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—NGF—atopic dermatitis	7.45e-06	0.00017	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	7.44e-06	0.000169	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	7.44e-06	0.000169	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	7.44e-06	0.000169	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	7.42e-06	0.000169	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	7.4e-06	0.000168	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	7.3e-06	0.000166	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—NGF—atopic dermatitis	7.3e-06	0.000166	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CCR5—atopic dermatitis	7.3e-06	0.000166	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	7.27e-06	0.000165	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	7.25e-06	0.000165	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—IL2—atopic dermatitis	7.24e-06	0.000165	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CXCL10—atopic dermatitis	7.22e-06	0.000164	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	7.2e-06	0.000164	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	7.2e-06	0.000164	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	7.18e-06	0.000163	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—NGF—atopic dermatitis	7.18e-06	0.000163	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL5—atopic dermatitis	7.18e-06	0.000163	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—CXCL8—atopic dermatitis	7.15e-06	0.000163	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—IL2—atopic dermatitis	7.14e-06	0.000162	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	7.1e-06	0.000161	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	7.09e-06	0.000161	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	7.09e-06	0.000161	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL5—atopic dermatitis	7.07e-06	0.000161	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL5—atopic dermatitis	7.05e-06	0.00016	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	6.99e-06	0.000159	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CCR5—atopic dermatitis	6.99e-06	0.000159	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CCL5—atopic dermatitis	6.98e-06	0.000159	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	6.97e-06	0.000159	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	6.94e-06	0.000158	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	6.94e-06	0.000158	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	6.92e-06	0.000157	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	6.92e-06	0.000157	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	6.92e-06	0.000157	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CCL5—atopic dermatitis	6.89e-06	0.000157	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—NGF—atopic dermatitis	6.86e-06	0.000156	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—IL2—atopic dermatitis	6.83e-06	0.000155	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	6.83e-06	0.000155	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	6.78e-06	0.000154	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	6.77e-06	0.000154	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	6.75e-06	0.000153	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	6.68e-06	0.000152	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	6.67e-06	0.000152	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	6.64e-06	0.000151	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	6.52e-06	0.000148	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—NGF—atopic dermatitis	6.47e-06	0.000147	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	6.44e-06	0.000146	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	6.43e-06	0.000146	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GLB1—atopic dermatitis	6.4e-06	0.000146	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NGF—atopic dermatitis	6.38e-06	0.000145	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	6.35e-06	0.000144	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	6.31e-06	0.000144	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CCR5—atopic dermatitis	6.29e-06	0.000143	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	6.22e-06	0.000141	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CCR5—atopic dermatitis	6.21e-06	0.000141	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—NFKBIA—atopic dermatitis	6.19e-06	0.000141	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PPARA—atopic dermatitis	6.18e-06	0.000141	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—IL2—atopic dermatitis	6.15e-06	0.00014	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	6.15e-06	0.00014	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ADSL—atopic dermatitis	6.13e-06	0.00014	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	6.12e-06	0.000139	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	6.1e-06	0.000139	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—IL2—atopic dermatitis	6.07e-06	0.000138	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	6.06e-06	0.000138	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	6.03e-06	0.000137	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	6.03e-06	0.000137	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	6.02e-06	0.000137	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	6.01e-06	0.000137	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	6e-06	0.000137	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PPARA—atopic dermatitis	6e-06	0.000136	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	5.97e-06	0.000136	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	5.92e-06	0.000135	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	5.9e-06	0.000134	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	5.9e-06	0.000134	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	5.83e-06	0.000133	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	5.81e-06	0.000132	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	5.8e-06	0.000132	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	5.8e-06	0.000132	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	5.76e-06	0.000131	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	5.73e-06	0.00013	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	5.72e-06	0.00013	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	5.65e-06	0.000129	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	5.64e-06	0.000128	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	5.6e-06	0.000127	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NGF—atopic dermatitis	5.56e-06	0.000126	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	5.55e-06	0.000126	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	5.54e-06	0.000126	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NGF—atopic dermatitis	5.53e-06	0.000126	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	5.51e-06	0.000125	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	5.48e-06	0.000125	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	5.48e-06	0.000125	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	5.41e-06	0.000123	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	5.38e-06	0.000122	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	5.38e-06	0.000122	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	5.36e-06	0.000122	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	5.35e-06	0.000122	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	5.33e-06	0.000121	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	5.29e-06	0.00012	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	5.29e-06	0.00012	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	5.27e-06	0.00012	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCL5—atopic dermatitis	5.27e-06	0.00012	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	5.27e-06	0.00012	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	5.26e-06	0.00012	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	5.26e-06	0.00012	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.25e-06	0.00012	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	5.23e-06	0.000119	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	5.19e-06	0.000118	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCL5—atopic dermatitis	5.18e-06	0.000118	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	5.16e-06	0.000117	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	5.15e-06	0.000117	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	5.12e-06	0.000116	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	5.11e-06	0.000116	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	5.08e-06	0.000116	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	5.04e-06	0.000115	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	5.03e-06	0.000114	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	5.02e-06	0.000114	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	4.93e-06	0.000112	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NGF—atopic dermatitis	4.88e-06	0.000111	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PPARA—atopic dermatitis	4.87e-06	0.000111	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	4.86e-06	0.000111	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NGF—atopic dermatitis	4.8e-06	0.000109	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NGF—atopic dermatitis	4.79e-06	0.000109	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.79e-06	0.000109	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	4.78e-06	0.000109	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	4.77e-06	0.000109	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	4.75e-06	0.000108	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCR5—atopic dermatitis	4.75e-06	0.000108	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	4.72e-06	0.000107	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	4.7e-06	0.000107	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	4.68e-06	0.000107	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	4.67e-06	0.000106	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCR5—atopic dermatitis	4.66e-06	0.000106	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL2—atopic dermatitis	4.64e-06	0.000106	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	4.59e-06	0.000104	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	4.58e-06	0.000104	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	4.58e-06	0.000104	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	4.57e-06	0.000104	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	4.56e-06	0.000104	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL2—atopic dermatitis	4.56e-06	0.000104	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	4.47e-06	0.000102	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PPARA—atopic dermatitis	4.47e-06	0.000102	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	4.44e-06	0.000101	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	4.41e-06	0.0001	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	4.38e-06	9.97e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	4.37e-06	9.94e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	4.37e-06	9.93e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	4.35e-06	9.9e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	4.29e-06	9.76e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	4.25e-06	9.67e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	4.22e-06	9.61e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL2—atopic dermatitis	4.22e-06	9.59e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—IL6—atopic dermatitis	4.2e-06	9.54e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL2—atopic dermatitis	4.19e-06	9.53e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	4.17e-06	9.48e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	4.16e-06	9.46e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL2—atopic dermatitis	4.1e-06	9.33e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	4.08e-06	9.28e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL2—atopic dermatitis	4.04e-06	9.18e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	4.03e-06	9.17e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	4.03e-06	9.16e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—IL6—atopic dermatitis	4.02e-06	9.14e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	3.96e-06	9.01e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	3.95e-06	8.99e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	3.88e-06	8.83e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	3.88e-06	8.82e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	3.86e-06	8.77e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL2—atopic dermatitis	3.85e-06	8.77e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	3.83e-06	8.72e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	3.8e-06	8.65e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	3.78e-06	8.59e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	3.75e-06	8.53e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	3.72e-06	8.45e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL2—atopic dermatitis	3.63e-06	8.27e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—IL6—atopic dermatitis	3.62e-06	8.22e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	3.6e-06	8.2e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL2—atopic dermatitis	3.59e-06	8.16e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—IL6—atopic dermatitis	3.57e-06	8.12e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	3.55e-06	8.07e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	3.39e-06	7.7e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PPARA—atopic dermatitis	3.37e-06	7.67e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	3.34e-06	7.61e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	3.3e-06	7.51e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	3.27e-06	7.44e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	3.25e-06	7.4e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	3.24e-06	7.36e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	3.22e-06	7.33e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PPARA—atopic dermatitis	3.18e-06	7.22e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	3.16e-06	7.2e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL2—atopic dermatitis	3.13e-06	7.11e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	3.11e-06	7.08e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	3.11e-06	7.07e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL2—atopic dermatitis	3.11e-06	7.07e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	3.09e-06	7.04e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	3.02e-06	6.88e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	3.01e-06	6.84e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	2.98e-06	6.78e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	2.98e-06	6.77e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	2.96e-06	6.74e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	2.88e-06	6.54e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	2.87e-06	6.53e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	2.86e-06	6.51e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	2.82e-06	6.43e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	2.82e-06	6.41e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	2.78e-06	6.33e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	2.77e-06	6.29e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL2—atopic dermatitis	2.74e-06	6.24e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	2.74e-06	6.23e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL6—atopic dermatitis	2.73e-06	6.21e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL2—atopic dermatitis	2.7e-06	6.14e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL2—atopic dermatitis	2.69e-06	6.13e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	2.69e-06	6.11e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL6—atopic dermatitis	2.68e-06	6.1e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	2.64e-06	6.01e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	2.63e-06	5.98e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	2.57e-06	5.85e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	2.53e-06	5.74e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	2.48e-06	5.65e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	2.48e-06	5.64e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6—atopic dermatitis	2.48e-06	5.64e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6—atopic dermatitis	2.46e-06	5.6e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	2.46e-06	5.59e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	2.44e-06	5.56e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	2.43e-06	5.53e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6—atopic dermatitis	2.41e-06	5.48e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6—atopic dermatitis	2.37e-06	5.4e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6—atopic dermatitis	2.27e-06	5.15e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	2.26e-06	5.14e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6—atopic dermatitis	2.14e-06	4.86e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6—atopic dermatitis	2.11e-06	4.79e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.08e-06	4.72e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	1.9e-06	4.33e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6—atopic dermatitis	1.84e-06	4.18e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6—atopic dermatitis	1.83e-06	4.16e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	1.78e-06	4.04e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	1.75e-06	3.98e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6—atopic dermatitis	1.61e-06	3.67e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6—atopic dermatitis	1.59e-06	3.61e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6—atopic dermatitis	1.58e-06	3.6e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	1.55e-06	3.53e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	1.44e-06	3.28e-05	CbGpPWpGaD
